AZD-3147 - CAS 1101810-02-9
Catalog number:
1101810-02-9
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C24H31N5O4S2
Molecular Weight:
517.66
COA:
Inquire
Targets:
mTOR
Description:
AZD-3147 is an extremely potent and selective dual inhibitor of mTORC1 and mTORC2. It exhibits >300-fold selectivity for mTOR over PI 3-kinase isoforms. It has physicochemical and pharmacokinetic properties suitable for development as a potential clinical candidate.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Appearance:
White solid
Synonyms:
AZD3147;(S)-1-(4-(4-(1-(cyclopropylsulfonyl)cyclopropyl)-6-(3-methylmorpholino)pyrimidin-2-yl)phenyl)-3-(2-hydroxyethyl)thiourea
Solubility:
Soluble to 100 mM in DMSO and to 100 mM in 1eq. HCl
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
AZD-3147 has physicochemical and pharmacokinetic properties suitable for development as a potential clinical candidate.
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
Boiling Point:
696.7±65.0 °C | Condition: Press: 760 Torr
Density:
1.45±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
JWGVUDPAMQEIJU-INIZCTEOSA-N
InChI:
InChI=1S/C24H31N5O4S2/c1-16-15-33-13-11-29(16)21-14-20(24(8-9-24)35(31,32)19-6-7-19)27-22(28-21)17-2-4-18(5-3-17)26-23(34)25-10-12-30/h2-5,14,16,19,30H,6-13,15H2,1H3,(H2,25,26,34)/t16-/m0/s1
Canonical SMILES:
CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=O)(=O)C4CC4)C5=CC=C(C=C5)NC(=S)NCCO
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related mTOR Products


CAS 159351-69-6 Everolimus

Everolimus
(CAS: 159351-69-6)

Everolimus is an inhibitor of mammalian target of rapamycin (mTOR) with an immunosuppressive activity which is comparable to that of rapamycin. It inhibits cyto...

CAS 1032754-93-0 Apitolisib

Apitolisib
(CAS: 1032754-93-0)

Apitolisib, also known as GDC-0980 and RG7422;  or GNE390, is a dual PI3 kinase/mTOR inhibitor,   is also an orally available agent targeting phosphatidylinosit...

CAS 1394076-92-6 GNE-317

GNE-317
(CAS: 1394076-92-6)

GNE-317 is a potent and selective PI3K inhibitor with potential anticncer activity. GNE-317 targets the PI3K pathway and can cross the Blood–Brain Barrier. GNE-...

CAS 1144068-46-1 WYE-125132

WYE-125132
(CAS: 1144068-46-1)

WYE-125132, also known as WYE-132, is a highly potent, ATP-competitive, and specific mTOR kinase inhibitor. WYE-132 inhibited mTORC1 and mTORC2 in diverse canc...

CAS 915019-65-7 Dactolisib

Dactolisib
(CAS: 915019-65-7)

Dactolisib, also known as BEZ235, is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BEZ235 speci...

CAS 1207358-59-5 mTOR-IN-1

mTOR-IN-1
(CAS: 1207358-59-5)

Selective inhibitors of mammalian target of rapamycin (mTOR) kinase based upon saturated heterocycles fused to a pyrimidine core were designed and synthesized. ...

CC-115
(CAS: 1228013-15-7)

CC-115, a DNA-PK and mTOR inhibitor, has been found to have probable anticarcinoma effect. IC50:13 nM and 21 nM for DNA-PK and mTOR respectively.

CAS 914913-88-5 Palomid 529

Palomid 529
(CAS: 914913-88-5)

Palomid 529, also known as P529, is a novel PI3K/Akt/mTOR inhibitor. Palomid 529 (P529) inhibits the TORC1 and TORC2 complexes and shows both inhibition of Akt ...

CAS 1676893-24-5 NSC781406

NSC781406
(CAS: 1676893-24-5)

NSC781406 demonstrates potent PI3K inhibition (PI3Kα IC50=2.0 nM) and is a highly potent mTOR inhibitor, with reasonable liver microsome stability.

CC-223
(CAS: 1228013-30-6)

CC-223, a mTOR kinase inhibitor, has been found to be effective in inducing the apoptosis and reducing the proliferation of tumor cells. It is still under Phase...

CAS 1246535-95-4 Desmethyl-VS-5584

Desmethyl-VS-5584
(CAS: 1246535-95-4)

Desmethyl-VS-5584, a demethyl analogue of VS-5584, is a PI3K/mTOR kinase inhibitor for the treatment of cancer.

CAS 1223002-54-7 QL-IX-55

QL-IX-55
(CAS: 1223002-54-7)

The functional target of QL-IX-55 is the ATP-binding site of TOR2 as evidenced by the discovery of resistant alleles of TOR2 through rational design and unbiase...

CAS 1207360-89-1 GDC-0349

GDC-0349
(CAS: 1207360-89-1)

GDC-0349 is a small molecule anticaner drug candidate, being developed by Genentech. As of July 2012, Genentech has filed phase I trial of GDC-0349 for evaluati...

CAS 1223001-51-1 Torin 2

Torin 2
(CAS: 1223001-51-1)

Torin 2 inhibits of ATM/ATR/DNA-PK with EC50 of 28 nM/35 nM/118 nM,in PC3 cell lines respectively.

AZD-3147
(CAS: 1101810-02-9)

AZD-3147 is an extremely potent and selective dual inhibitor of mTORC1 and mTORC2. It exhibits >300-fold selectivity for mTOR over PI 3-kinase isoforms. It has ...

SMER18
(CAS: 944153-47-3)

SMER18 is a small molecule enhancer of rapamycin. It act as a mTOR-independent autophagy inducer. It is a positive regulators of autophagy acting independently ...

CAS 1062161-90-3 WYE-687

WYE-687
(CAS: 1062161-90-3)

WYE-687 is a potent and ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM.

CAS 1009298-59-2 AZD-2014

AZD-2014
(CAS: 1009298-59-2)

AZD2014 is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. AZD2014 inhibits the activity o...

CAS 1086062-66-9 Omipalisib

Omipalisib
(CAS: 1086062-66-9)

Omipalisib, also known as GSK2126458, is asmall-molecule pyridylsulfonamide inhibitor of phosphatidylinositol 3-kinase (PI3K) with potential antineoplastic acti...

CAS 1224844-38-5 MLN0128

MLN0128
(CAS: 1224844-38-5)

MLN0128, also known as INK128, is a TORC1/2 inhibitor, is also an orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR co...

Quick Inquiry

Verification code

Featured Items